The Potential Role of Renal Denervation in the Management of Heart Failure
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Sympathetic nervous system activation in patients with heart failure is one of the main pathophysiologic mechanisms associated with the worse outcomes. Pharmacotherapies targeting neurohormonal activation have been at the center of heart failure management. Despite the advancement of therapies and the available treatments, heart failure continues to have an overall poor prognosis. Renal denervation was originally developed to lower systemic blood pressure in patients with poorly controlled hypertension, by modulating sympathetic outflow. However, more recently, multiple studies have investigated the effect of renal denervation in heart failure patients with both preserved (HFpEF) and reduced ejection fractions (HFrEF). This paper provides an overview of the potential effect of renal denervation in altering the various pathophysiologic, sympathetically mediated pathways that contribute to heart failure, and reviews the literature that supports its future use in those patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, RDN-induced reductions in MSNA18 and beneficial effects of RDN on conditions that are not traditionally thought to be driven by the kidney, including heart failure and arrthymia19, cannot be wholly explained by alterations in body fluid homeostasis.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957 · cited 1×
“Large scale clinical trials, such as PARADIGM-HF, demonstrated that combining a neprilysin inhibitor (Sacubitril) with valsartan was superior to the standard guideline-directed therapy with a RAAS inhibitor alone (enalapril) [33].”
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107038 · Cited by 4,874
Spironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Heidenreich, P. A., Albert, N. M., Allen, L. A., Bluemke, D. A., Butler, J., Fonarow, G. C., Ikonomidis, J. S., Khavjou, O., Konstam, M. A., Maddox, T. M., et al. (2013) · Circulation: Heart Failure · doi:10.1161/hhf.0b013e318291329a · Cited by 2,804
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908655 · Cited by 2,430
Zannad, F., Ferreira, J. P., Pocock, S. J., Anker, S. D., Butler, J., Filippatos, G., Brueckmann, M., Ofstad, A. P., Pfarr, E., Jamal, W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31824-9 · Cited by 1,408
Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132 · cited 1×
“They produce neuro-hormonal modulation via the activation of the renin–angiotensin–aldosterone system (RAAS) in response to hypoperfusion, leading to sodium retention, vasoconstriction, and intravascular volume depletion [5].”
BackgroundHeart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.011 · Cited by 931
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Mann, D. L., Kent, R. L., Parsons, B., & Cooper, G. (1992) · Circulation · doi:10.1161/01.cir.85.2.790 · Cited by 866
Kandzari, D. E., Böhm, M., Mahfoud, F., Townsend, R. R., Weber, M. A., Pocock, S., Tsioufis, K., Tousoulis, D., Choi, J. W., East, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30951-6 · Cited by 793
Azizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31082-1 · Cited by 740 · cited 1×
“While earlier studies failed to demonstrate a clear clinical benefit, with the redefinition of ablation technology and endovascular techniques, more recent trials demonstrated RDN to be able to provide an effective blood pressure control [17,18].”
ResultNeurohormonal activation in heart failure with reduced ejection fraction
Hartupee, J., & Mann, D. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.163 · Cited by 709
Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Böhm, M., & Hoppe, U. C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.034 · Cited by 501
Pokushalov, E., Romanov, A., Corbucci, G., Artyomenko, S., Baranova, V., Turov, A., Shirokova, N., Karaskov, A., Mittal, S., & Steinberg, J. S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.036 · Cited by 432
Davies, J. E., Manisty, C. H., Petraco, R., Barron, A. J., Unsworth, B., Mayet, J., Hamady, M., Hughes, A. D., Sever, P. S., Sobotka, P. A., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.019 · Cited by 296
Impact of Medication Nonadherence on Hospitalizations and Mortality in Heart Failure
Fitzgerald, A. A., Powers, J. D., Ho, P. M., Maddox, T. M., Peterson, P. N., Allen, L. A., Masoudi, F. A., Magid, D. J., & Havranek, E. P. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.011 · Cited by 284
Esler, M. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00832.2009 · Cited by 243
Steinberg, J. S., Shabanov, V., Ponomarev, D., Losik, D., Ivanickiy, E., Kropotkin, E., Polyakov, K., Ptaszynski, P., Keweloh, B., Yao, C. J., et al. (2020) · JAMA · doi:10.1001/jama.2019.21187 · Cited by 243 · cited 1×
“Recently, there has been an increasing interest in RDN as a treatment for chronic heart failure and tachy-arrhythmias, such as atrial fibrillation, with multiple studies demonstrating its efficacy, up to 1-year follow-up [21,22].”
BackgroundFunctional role of renal afferents.
Stella, A., & Zanchetti, A. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.3.659 · Cited by 215
Conrad, N., Judge, A., Canoy, D., Tran, J., Pinho-Gomes, A.-C., Millett, E. R. C., Salimi-Khorshidi, G., Cleland, J. G., McMurray, J. J. V., & Rahimi, K. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3593 · Cited by 197
BÖHM, M., BEUCKELMANN, D., BROWN, L., FEILER, G., LORENZ, B., NÄBAUER, M., KEMKES, B., & ERDMANN, E. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062577 · Cited by 196
Mahfoud, F., Urban, D., Teller, D., Linz, D., Stawowy, P., Hassel, J.-H., Fries, P., Dreysse, S., Wellnhofer, E., Schneider, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu093 · Cited by 162
Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure
Petersson, M., Friberg, P., Eisenhofer, G., Lambert, G., & Rundqvist, B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi184 · Cited by 155
Remo, B. F., Preminger, M., Bradfield, J., Mittal, S., Boyle, N., Gupta, A., Shivkumar, K., Steinberg, J. S., & Dickfeld, T. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2013.12.038 · Cited by 153
Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs
Linz, D., WIRTH, K. J., Ukena, C., Mahfoud, F., Pöss, J., Linz, B. M., Böhm, M., & Neuberger, H. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.015 · Cited by 148
Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System
Sharp, T. E., Polhemus, D. J., Li, Z., Spaletra, P., Jenkins, J. S., Reilly, J. P., White, C. J., Kapusta, D. R., Lefer, D. J., & Goodchild, T. T. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2186 · Cited by 108
Sympathetic Activation in Heart Failure and Its Treatment With β-Blockade
Pepper, G. S., & Lee, R. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.225 · Cited by 104
Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention.
Francis, G. S., McDonald, K., & Cohn, J. N. (1993) · PubMed · Cited by 100
Medical Therapies for Heart Failure With Preserved Ejection Fraction
Kjeldsen, S. E., von Lueder, T. G., Smiseth, O. A., Wachtell, K., Mistry, N., Westheim, A. S., Hopper, I., Julius, S., Pitt, B., Reid, C. M., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.14057 · Cited by 98
Polhemus, D. J., Trivedi, R. K., Gao, J., Li, Z., Scarborough, A. L., Goodchild, T. T., Varner, K. J., Xia, H., Smart, F. W., Kapusta, D. R., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.056 · Cited by 97
Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction
Kresoja, K.-P., Rommel, K.-P., Fengler, K., von Roeder, M., Besler, C., Lücke, C., Gutberlet, M., Desch, S., Thiele, H., Böhm, M., et al. (2021) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007421 · Cited by 96
Perlini, S., Palladini, G., Ferrero, I., Tozzi, R., Fallarini, S., Facoetti, A., Nano, R., Clari, F., Busca, G. A., Fogari, R., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000185689.65045.4c · Cited by 82
Non-pharmacological modulation of the autonomic tone to treat heart failure
Singh, J. P., Kandala, J., & John Camm, A. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht436 · Cited by 73
Chen, W., Ling, Z., Xu, Y., Liu, Z., Su, L., Du, H., Xiao, P., Lan, X., Shan, Q., & Yin, Y. (2017) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26475 · Cited by 66
Renal Denervation and Heart Failure
Böhm, M., Ewen, S., Kindermann, I., Linz, D., Ukena, C., & Mahfoud, F. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.83 · Cited by 61
Hopper, I., Gronda, E., Hoppe, U. C., Rundqvist, B., Marwick, T. H., Shetty, S. V., Hayward, C., Lambert, T., Hering, D., Esler, M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.06.004 · Cited by 59
Renal Denervation to Treat Heart Failure
Sharp, T. E., & Lefer, D. J. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031620-093431 · Cited by 59
Polhemus, D. J., Gao, J., Scarborough, A. L., Trivedi, R. K., McDonough, K. H., Goodchild, T. T., Smart, F. W., Kapusta, D. R., & Lefer, D. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.308278 · Cited by 55
Zhang, W., Zhou, Q., Lu, Y., Li, Y., Zhang, L., Zhang, J., Xing, Q., Lv, W., Cheng, X., Zhang, G., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009938 · Cited by 51
Gao, J., Yang, W., & Liu, Z. (2018) · Cardiology Journal · doi:10.5603/cj.a2018.0028 · Cited by 49
Variation in Medication Adherence in Heart Failure
Zhang, Y., Wu, S.-H., Fendrick, A. M., & D, K. B. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2509 · Cited by 44
Renal denervation for refractory ventricular arrhythmias
Bradfield, J. S., Vaseghi, M., & Shivkumar, K. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.05.006 · Cited by 41
Selective vs. Global Renal Denervation: a Case for Less Is More
Fudim, M., Sobotka, A., Yin, Y., Wang, J. W., Levin, H. R., Esler, M., Wang, J., & Sobotka, P. A. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0838-2 · Cited by 39
Renal Denervation for the Management of Refractory Ventricular Arrhythmias
Hawson, J. J., Harmer, J. A., Cowan, M., Virk, S. A., Campbell, T. G., Bennett, R. G., Anderson, R. D., Kalman, J. M., Lee, G., & Kumar, S. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.07.019 · Cited by 36
Nawar, K., Mohammad, A., Johns, E. J., & Abdulla, M. H. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00658-0 · Cited by 32 · cited 1×
“Recently, there has been an increasing interest in RDN as a treatment for chronic heart failure and tachy-arrhythmias, such as atrial fibrillation, with multiple studies demonstrating its efficacy, up to 1-year follow-up [21,22].”
BackgroundZheng, H., Liu, X., Sharma, N. M., & Patel, K. P. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00999.2015 · Cited by 31
Gao, J., Xie, Y., Yang, W., Zheng, J., & Liu, Z. (2016) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2016.07.007 · Cited by 27
Dai, Z., Yu, S., Zhao, Q., Meng, Y., Huang, H., Tang, Y., Wang, X., Xiao, J., Wang, X., & Huang, C. (2014) · EuroIntervention · doi:10.4244/eijv10i3a65 · Cited by 25
Dai, Q., Lü, J., Wang, B., & Ma, G. (2015) · Europe PMC (PubMed Central) · Cited by 24
Renal Denervation for Patients With Heart Failure: Making a Full Circle
Fudim, M., Sobotka, P. A., Piccini, J. P., & Patel, M. R. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.121.008301 · Cited by 23
Renal denervation for the management of resistant hypertension
Patel, H. C., Hayward, C., Vassiliou, V. S., Patel, K., Howard, J. P., & Mario, C. D. (2015) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s65632 · Cited by 22
Dróżdż, T., Jastrzębski, M., Moskal, P., Kusiak, A., Bednarek, A., Styczkiewicz, K., Jankowski, P., & Czarnecka, D. (2019) · Advances in Interventional Cardiology · doi:10.5114/aic.2019.86017 · Cited by 18
Renal Denervation for Chronic Heart Failure: Background and Pathophysiological Rationale
Böhm, M., Ewen, S., & Mahfoud, F. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.0231 · Cited by 16
Xia, Z., Li, H., Pellegrino, P. R., Schiller, A. M., Harrold, L. D., Lobato, R. L., Lisco, S. J., Zucker, I. H., & Wang, H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08847 · Cited by 16
Wang, L., Song, L., Li, C., Feng, Q., Xu, M., Li, Z., & Lu, C. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0828-y · Cited by 14
Dróżdż, T., Jastrzębski, M., Moskal, P., et al. (2019) · PubMed · doi:10.5114/aic.2019.8601 · Cited by 12
Effect of renal denervation on long-term outcomes in patients with resistant hypertension
Liang, B., Liang, Y., Li, R., & Gu, N. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01309-3 · Cited by 8
Renal Denervation Therapy for the Treatment of Arrhythmias: Is the Sky the Limit?
Bhave, P. D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005342 · Cited by 6
Cited by
Renal nerves in physiology, pathophysiology and interoception
Evans, L. C., Dayton, A., & Osborn, J. W. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00893-3 · Cited by 46
Cardiorenal Syndromes and Their Role in Water and Sodium Homeostasis
Salajová, K. B., Malík, J., & Valeriánová, A. (2024) · Physiological Research · doi:10.33549/physiolres.935110 · Cited by 29
The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF
Triposkiadis, F. K., Briasoulis, Α., Sarafidis, P. A., Magouliotis, D. E., Athanasiou, T., PARASKEVAIDIS, I. A., Skoularigis, J. S., & Xanthopoulos, A. V. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206486 · Cited by 20
Goyal, A., Jain, H., Verma, A., Jain, J., Shamim, U., Kanagala, S. G., Motwani, J., Dey, R. C., Chunawala, Z. S., Sohail, A. H., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102196 · Cited by 17
Shen, Z., Zhang, Y., Bu, G., & Fang, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112778 · Cited by 17
Metadata
- Authors
- Kassab, K., Soni, R., Kassier, A., & Fischell, T. A.
- Affiliations
- Borgess Medical Center (US)
- Corresponding author
- Kassab, Kameel
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2022-07-17
- Volume
- 11
- Issue
- 14
- Pages
- 4147
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9324976
- OpenAlex
- W4285731655
- Cited by
- 19
- References
- 60
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 3
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- renal denervation, heart failure, sympathetic activation, heart failure with preserved ejection fraction, heart failure with reduced ejection fraction, neurohormonal activation, hypertension, sympathetic outflow, heart failure prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
